# ACOD-itaconate in macrophage attenuates oxidative stress and inflammation in benign airway stenosis by upregulating and transferring FTH1

**Authors:** YiLin Chen, ChengFei Xu, Tao Luo, DongChen Shi, XinYi Guo, ChengCheng Yang, YuChao Dong, HaiDong Huang, YiFei Zhang, Zhe Zong, XiaoMin Wang, ZhiRu Xu, Yue Shi, ChaoFeng Han, Hui Shi, Chong Bai

PMC · DOI: 10.1016/j.redox.2026.104133 · 2026-03-20

## TL;DR

This study shows that ACOD1-itaconate in macrophages reduces inflammation and fibrosis in airway diseases by transferring FTH1 to fibroblasts.

## Contribution

The study identifies the ACOD1-itaconate axis as a novel metabolic regulator of inflammation and fibrosis in airway diseases.

## Key findings

- ACOD1 deficiency worsens inflammation and fibrosis in benign airway stenosis.
- 4-OI reduces oxidative stress and inflammation by upregulating FTH1 in macrophages.
- Exosomal FTH1 transfer via SCARA5 induces fibroblast ferroptosis and reduces fibrosis.

## Abstract

The oxidative stress of macrophage plays pivotal roles of acute and chronic inflammation and chronic fibrotic phases, in which the metabolic mechanism needs to be further explored. In our research, multi-omics analyses of human and murine during Benign airway stenosis (BAS) biopsy identified ACOD1 as a hallmark of immunometabolic regulation during acute inflammation stage. ACOD1 knockout aggravated both acute and chronic inflammation, which increased the granulation tissue formation. The ACOD1-itaconate axis, along with its derivative, 4-octyl itaconate (4-OI), orchestrated acute and chronic inflammation, which attenuated the fibrosis of BAS. 4-OI upregulated FTH1 expression in macrophages by activating NRF2, which effectively suppressed oxidative stress and acute inflammation. Furthermore, 4-OI promoted the packaging of FTH1 into macrophage-derived exosomes, which were transferred to fibroblasts in a SCARA5-dependent manner, inducing fibroblast ferroptosis and alleviating chronic fibrosis. In sum, this study illustrates that the ACOD1-itaconate metabolic axis decreases oxidative stress and inflammation in macrophage, which attenuates fibrosis by inducing FTH1 transfer, offering a therapeutic target for fibrotic airway diseases.

•scRNA sequence reveals that ACOD1 is significantly upregulated during BAS.•ACOD1 deficiency aggravates acute and chronic inflammation of BAS.•Itaconate derivative 4-OI attenuates acute and chronic inflammation of BAS.•4-OI-induced high expression of FTH1 in macrophages restricts oxidative stress and acute inflammation.•Macrophage exosomal FTH1 transferred via SCARA5 induces fibroblast ferroptosis to attenuate BAS inflammation and fibrosis.

scRNA sequence reveals that ACOD1 is significantly upregulated during BAS.

ACOD1 deficiency aggravates acute and chronic inflammation of BAS.

Itaconate derivative 4-OI attenuates acute and chronic inflammation of BAS.

4-OI-induced high expression of FTH1 in macrophages restricts oxidative stress and acute inflammation.

Macrophage exosomal FTH1 transferred via SCARA5 induces fibroblast ferroptosis to attenuate BAS inflammation and fibrosis.

## Linked entities

- **Genes:** ACOD1 (aconitate decarboxylase 1) [NCBI Gene 730249], FTH1 (ferritin heavy chain 1) [NCBI Gene 2495], GABPA (GA binding protein transcription factor subunit alpha) [NCBI Gene 2551], SCARA5 (scavenger receptor class A member 5) [NCBI Gene 286133]
- **Chemicals:** itaconate (PubChem CID 811), 4-octyl itaconate (PubChem CID 14239884), 4-OI (PubChem CID 162368299)

## Full-text entities

- **Genes:** Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 14433] {aka Gapd}, Nos2 (nitric oxide synthase 2, inducible) [NCBI Gene 18126] {aka MAC-NOS, NOS-II, Nos-2, Nos2a, i-NOS, iNOS}, Cd63 (CD63 antigen) [NCBI Gene 12512] {aka ME491, Tspan30}, SCARA5 (scavenger receptor class A member 5) [NCBI Gene 286133] {aka NET33, Tesr}, FTH1 (ferritin heavy chain 1) [NCBI Gene 2495] {aka FHC, FTH, FTHL6, HFE5, NBIA9, PIG15}, ACOD1 (aconitate decarboxylase 1) [NCBI Gene 730249] {aka CAD, IRG1}, Cd81 (CD81 antigen) [NCBI Gene 12520] {aka Tapa-1, Tapa1, Tspan28}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Canx (calnexin) [NCBI Gene 12330] {aka 1110069N15Rik, Cnx, D11Ertd153e}, Acod1 (aconitate decarboxylase 1) [NCBI Gene 16365] {aka CAD, Irg1}, Adgre1 (adhesion G protein-coupled receptor E1) [NCBI Gene 13733] {aka DD7A5-7, EGF-TM7, Emr1, F4/80, Gpf480, Ly71}, Scara5 (scavenger receptor class A, member 5) [NCBI Gene 71145] {aka 4932433F15Rik, 4933425F03Rik, Tesr}, Acta2 (actin alpha 2, smooth muscle, aorta) [NCBI Gene 11475] {aka 0610041G09Rik, Actvs, SMAalpha, SMalphaA, a-SMA, alphaSMA}, Cd68 (CD68 antigen) [NCBI Gene 12514] {aka Lamp4, Scard1, gp110}, Hif1a (hypoxia inducible factor 1, alpha subunit) [NCBI Gene 15251] {aka HIF-1-alpha, HIF1-alpha, HIF1alpha, MOP1, bHLHe78}, NFE2L2 (NFE2 like bZIP transcription factor 2) [NCBI Gene 4780] {aka IMDDHH, NRF2, Nrf-2}, GPX4 (glutathione peroxidase 4) [NCBI Gene 2879] {aka GPx-4, GSHPx-4, MCSP, PHGPx, SMDS, snGPx}, Nfe2l2 (nuclear factor, erythroid derived 2, like 2) [NCBI Gene 18024] {aka Nrf2}, Keap1 (kelch-like ECH-associated protein 1) [NCBI Gene 50868] {aka INRF2, mKIAA0132}, Tsg101 (tumor susceptibility gene 101) [NCBI Gene 22088] {aka CC2}, Fth1 (ferritin heavy polypeptide 1) [NCBI Gene 14319] {aka FHC, Fth, HFt, MFH}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, VIM (vimentin) [NCBI Gene 7431], Eif1a (eukaryotic translation initiation factor 1A) [NCBI Gene 13664] {aka Ef1a, Eftu, Eif4c, eIF-1A, eIF-4C}, ACTA1 (actin alpha 1, skeletal muscle) [NCBI Gene 58] {aka ACTA, ASMA, CFTD, CFTD1, CFTDM, CMYO2A}
- **Diseases:** granuloma (MESH:D006099), edema (MESH:D004487), granulomatous hyperplasia (MESH:D006965), Inflammatory diseases (MESH:D007249), infectious (MESH:D003141), hypoxic (MESH:D002534), airway injury (MESH:D000402), tracheal injury (MESH:D008476), 4-OI (MESH:D053632), sepsis (MESH:D018805), tissue injury (MESH:D017695), fibrosis (MESH:D005355), UMAP (MESH:C567162), dislocation (MESH:D004204), ischemic (MESH:D002545), myocardial infarction (MESH:D009203), autoimmune diseases (MESH:D001327), airway diseases (MESH:D029424), dyspnea (MESH:D004417), ischemia (MESH:D007511), OI (OMIM:613848), BAS (MESH:D003251), acute (MESH:D000208), Tracheal stenosis (MESH:D014135), trachea injury (MESH:D055090), infection (MESH:D007239)
- **Chemicals:** water (MESH:D014867), polyacrylamide (MESH:C016679), DEPC (MESH:D004047), saline (MESH:D012965), PEG300 (MESH:C000595211), Itaconate (MESH:C005229), formic acid (MESH:C030544), DiD (MESH:D017878), formamide (MESH:C031066), S (MESH:D013455), LPS (MESH:D008070), Tween-80 (MESH:D011136), CO2 (MESH:D002245), hematoxylin (MESH:D006416), methanol (MESH:D000432), corn oil (MESH:D003314), DMSO (MESH:D004121), penicillin (MESH:D010406), H&amp;E (MESH:D006371), PBS (MESH:D007854), Phen Green SK (MESH:C431805), formaldehyde (MESH:D005557), acetonitrile (MESH:C032159), 4-HNE (MESH:C027576), xylazine (MESH:D014991), ROS (MESH:D017382), paraffin (MESH:D010232), GW4869 (MESH:C468773), isoflurane (MESH:D007530), Lipid (MESH:D008055), uranyl acetate (MESH:C005460), agar (MESH:D000362), xylene (MESH:D014992), 4-OI (MESH:C000708109), alcohols (MESH:D000438), DAPI (MESH:C007293), Iron (MESH:D007501), SDS (MESH:D012967), ampicillin (MESH:D000667), DAB (MESH:C000469), BODIPY (MESH:C095489), TCA (MESH:D014233), phalloidin (MESH:D010590), ethanol (MESH:D000431), DFO (MESH:D003676), streptomycin (MESH:D013307), PVDF (MESH:C024865), agarose (MESH:D012685), ACOD-itaconate (-)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]
- **Mutations:** T2A
- **Cell lines:** fibroblasts — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0594), Raw 264.7 — Mus musculus (Mouse), Mouse leukemia, Cancer cell line (CVCL_0493), THP-1 — Homo sapiens (Human), Childhood acute monocytic leukemia, Cancer cell line (CVCL_0006), Mc4 — Mus musculus (Mouse), Hybridoma (CVCL_C7H9), /6J — Homo sapiens (Human), Cutaneous melanoma, Cancer cell line (CVCL_W797)

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13010451/full.md

---
Source: https://tomesphere.com/paper/PMC13010451